SHIRUTO
– 30s
产品简介
BElixz SHIRUTO的独特配方具有高效能且经过发酵过程的小麦萃取物(IP-PA1)和协同营养素，包括维生素C和-葡聚糖，有助于支撑、维持及保持健康的身体。 BElixz SHIRUTO内含IP-PA1的发酵和生产过程已获得国际专利，从而确保IP-PA1的最佳品质。
|
价格
|
代码
|
|---|---|
|
RP SGD116.50
|
B0600003
|
GMP认证
严格和高标准的制造过程
HALAL认证
天然植物成分
适合素食者服用
日本进口
独特成分:
发酵小麦提取物（IP-PA1) – Helps 帮助增强健康
维生素C和β-葡聚糖 – 协同营养素，支持和维持健康的身体系统
健康效益
孩童
- 支持不断增长的需求
成人
- 支持现代生活需求
老人
- 支持黄金时代需求
DISCOVERY OF IP-PA1 AND ITS HEALTH BENEFITS:
MILESTONES
1982
Honorary Professor Den’ichi Mizuno of Tokyo University started the project on the function of macrophages in maintaining health. Professor Gen-Ichiro Soma and Professor Hiroyuki Inagawa joined in the project.
1988
The macrophage activator found in wheat was discovered to be IP-PA1
1990
Research on the prevention and improvement of various diseases through oral ingestion of IP-PA1.
1992
Published about the effects of IP-PA1 on atopic dermatitis, improvement of hyperlipidaemia, prevention of gastric ulcer and decreasing of LDL cholesterol.
1997
Dr. Charles Janeway in the US discovered IP-PA1 receptors that appeared in macrophages. As a result, the macrophage activation mechanism of IP-PA1 was revealed and research on natural immunity progressed dramatically. In 2011, three researchers who contributed to the clarification of natural immunity system received the Nobel Prize in Physiology and Medicine.
2006
IP-PA1 was launched as a functional ingredient.
2010 to Present
The Innate Immunity Control Technology Research Association (certified by the Ministry of Economy, Trade and Industry of Japan) was established to conduct R&D through industry-academia cooperation for various applications of IP-PA1.
CIITRA: Control of Innate Immunity Technology Research Association
CIITRA: Control of Innate Immunity Technology Research Association
Natural Immunology Seminar Organized by CIITRA
独特的发酵及萃取过程已获得超过10个国家的专利
日本、美国、澳洲、欧洲、加拿大、中国、韩国、印度、新加坡、
台湾、俄罗斯等。
